NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Petrobras Brasileiro (ticker: PBR). The target price has been raised from $52 to $58. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Big 5 Sporting Goods Corporation (ticker: BGFV). The target price has been raised from $15 to $18. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Triple-S Management (ticker: GTS). The target price has been reduced from $20 to $18. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Anworth Mortgage (ticker: ANH). The target price has been reduced from $8.50 to $8. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on TreeHouse Foods (ticker: THS). The target price has been raised from $36 to $38. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Catalyst Health Solutions (ticker: CHSI). The target price has been raised from $26 to $37. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Health Net (ticker: HNT). The target price has been raised from $15 to $16. []

NEW YORK, November 4 (newratings.com) - Analysts at Thomas Weisel upgrade RehabCare (ticker: RHB) from "market weight" to "overweight." []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Emergency Medical Services (ticker: EMS). The target price has been raised from $47 to $55. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Forest Oil (ticker: FST). The target price has been raised from $19 to $22. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse upgrade General Dynamics (ticker: GD) from "neutral" to "outperform." The target price has been raised from $70 to $74. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Tenet Healthcare (ticker: THC). The target price has been raised from $6 to $7. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Chimera Investment Corp (ticker: CIM). The target price has been raised from $3.50 to $4. []

NEW YORK, November 4 (newratings.com) - Analysts at Wells Fargo Securities upgrade Gaylord Entertainment (ticker: GET) from "underperform" to "market perform." []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "underperform" rating on Rowan Co (ticker: RDC). The target price has been raised from $20 to $23. []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Cameron (ticker: CAM). The target price has been raised from $39 to $44. []

NEW YORK, November 4 (newratings.com) - Analysts at Wells Fargo Securities upgrade Cognizant Technology (ticker: CTSH) from "market perform" to "outperform." []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on MasterCard (ticker: MA). The target price has been raised from $255 to $260. []

NEW YORK, November 4 (newratings.com) - Analysts at UBS upgrade Hecla Mining (ticker: HL) from "sell" to "neutral." []

NEW YORK, November 4 (newratings.com) - Analysts at Credit Suisse reiterate their "outperform" rating on Anadarko Petroleum (ticker: APC). The target price has been raised from $60 to $64. []